A nice income stock. 90% of revenue is from the U.S. and report in USD. 70% of its operations are regulated, so cash flows are stable. The rest are renewable power generation operations under long-term agreements. They pay a 4.9% yield that they can increase 10% annually to 2021. You need a dividend-grower in this environment. (Analysts’ price target is $15.16)

After watching it, she bought it during the recent pullback under $103. They're transitioning their Office business into a subscriber-based business. Then, there's Windows. The last third is their Cloud business, which is well-positioned, just behind Amazon. They have a global business. Companies are comfortable with Microsoft so there's security and confidence in MSFT. The Cloud has a lot of room to grow. Boasts a strong balance sheet and a stable, recurring revenue stream. Strong balance sheet; they are net cash positive, actually. They don't need the debt markets to finance growth. (Analysts’ price target is $125.69)

He sold it when DIS spun their wheels with ESPN and ABC, but re-bought it earlier this yearly when they did a deal with 20th Century Fox to get into the streaming business. Disney and Fox have amazing film libraries--and DIS also got 60% control of Hulu. A lot of traction here. (Analysts’ price target is $122.30)

He likes medical devices – worldwide hospital spending, changing demographics. It has great tailwinds. They are less politically charged than drug prices.

They have 18% top line growth and are killing it in cloud. It has recurring revenue and high growth. It is not trading at a crazy multiple. He thinks it can hang in in a downturn. (Analysts’ price target is $125.69)

They've done a good transformation and have cut costs. In 2016, they starting changing their model with new products (i.e. all-day breakfast). Since 2016, we've seen higher highs and lows and a definite uptrend on their chart. It's a core holding of his. (Analysts’ price target is $192.82)

This is a buy and hold. They are a market disrupter. They are a global presence. They have had 33 straight quarters of 20% growth. The forward P/E is 24X which is very reasonable. Yield = 0% (Analysts’ price target is $1349.36)

This is more of a trade. They beat earnings and have strong technicals. It is trending positive and he likes utilities. Their revenue is very stable. Yield = 4.0% (Analysts’ price target is $47.79)